Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-06 · accession 0000899243-22-025827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-08 | 2022-07-06 | CORT | BELANOFF JOSEPH K | CEO | M - OptEx | $2.08 | +800.0K | 800.0K | New | +$1.66M |
| D | 2022-07-08 | 2022-07-06 | CORT | BELANOFF JOSEPH K | CEO | F - Tax | $26.21 | -451.2K | 348.8K | -56% | -$11.83M |
| DMI | 2022-07-08 | 2022-07-06+ | CORT | BELANOFF JOSEPH K | CEO | S - Sale+OE | $26.27 | -335.0K | 2.48M | -12% | -$8.80M |
| D | 2022-07-08 | 2022-07-06 | CORT | BELANOFF JOSEPH K | CEO | M - OptEx | $0.00 | +800.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-06 | M | A | 800,000 | $2.08 | 800,000 | D Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 | — | — | (F5) Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2022-07-06 | F | D | 451,189 | $26.21 | 348,811 | D Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 | — | — | (F5) Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. |
| 3 | Common | Common Stock | 2022-07-06 | S | D | 279,908 | $26.27 | 2,538,218 | I | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.21 to $26.65. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. |
| 4 | Common | Common Stock | 2022-07-07 | S | D | 55,111 | $26.26 | 2,483,107 | I | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.21 to $26.41. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. |
| 5 | Derivative | Stock option (right to buy) | 2022-07-06 | M | A | 800,000 | $0.00 | 0 | D | $2.08 · — to 2023-01-30 | 800,000 Common Stock | (F6) Fully exercisable. |